Skip Navigation

Create free account

Allergan trading at a zero pipeline valuation: Evercore's Umer Raffat

In this video

Allergan trading at a zero pipeline valuation: Evercore's Umer Raffat

After being named Institutional Investor's 2017 number-one biotech analyst, Umer Raffat of Evercore ISI discusses his picks for the biotech and specialty pharma sector.

02:23

Tue, Oct 10 20173:18 PM EDT

Current valuations make the tech sector look more attractive, says Wedbush's Sahak Manuelian

Current valuations make the tech sector look more attractive, says Wedbush's Sahak Manuelian

There's still a sneaker boom among consumers, says Evercore's Omar Saad

There's still a sneaker boom among consumers, says Evercore's Omar Saad

Here's what consumers need to understand about the banking industry

Here's what consumers need to understand about the banking industry

Treasury Sec. Janet Yellen: American public should be confident in the U.S. banking system

Treasury Sec. Janet Yellen: American public should be confident in the U.S. banking system

People should be really focused on risk management at this point, says JPMorgan’s Jason Hunter

People should be really focused on risk management at this point, says JPMorgan’s Jason Hunter

Current valuations make the tech sector look more attractive, says Wedbush's Sahak Manuelian

Current valuations make the tech sector look more attractive, says Wedbush's Sahak Manuelian

There's still a sneaker boom among consumers, says Evercore's Omar Saad

There's still a sneaker boom among consumers, says Evercore's Omar Saad

Here's what consumers need to understand about the banking industry

Here's what consumers need to understand about the banking industry

Treasury Sec. Janet Yellen: American public should be confident in the U.S. banking system

Treasury Sec. Janet Yellen: American public should be confident in the U.S. banking system

People should be really focused on risk management at this point, says JPMorgan’s Jason Hunter

People should be really focused on risk management at this point, says JPMorgan’s Jason Hunter